palmitoylcarnitine has been researched along with Rhabdomyolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastin, J; Behin, A; Bonnefont, JP; Djouadi, F | 1 |
| Brenton, DP; Cooper, M; Dathan, JR; Dewhurst, AG; Ellis, CJ | 1 |
2 other study(ies) available for palmitoylcarnitine and Rhabdomyolysis
| Article | Year |
|---|---|
Bezafibrate for an inborn mitochondrial beta-oxidation defect.
Topics: Adult; Bezafibrate; Carnitine O-Palmitoyltransferase; Genes, Recessive; Humans; Hypolipidemic Agents; Lipid Metabolism, Inborn Errors; Mitochondrial Diseases; Oxidation-Reduction; Palmitoylcarnitine; Pilot Projects; Quality of Life; Rhabdomyolysis; RNA, Messenger; Statistics, Nonparametric | 2009 |
Myoglobinuria: the importance of reaching a firm diagnosis--a patient with defective fatty acid oxidation.
Topics: Acute Kidney Injury; Dietary Fats; Fatty Acids; Humans; Lipid Metabolism, Inborn Errors; Male; Middle Aged; Myoglobinuria; Oxidation-Reduction; Palmitoylcarnitine; Rhabdomyolysis | 1990 |